NCT02680379 - Combined Treatment of Minocycline and Lovastatin to Treat Individuals With Fragile X Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

November 30, 2017

Conditions

Fragile X Syndrome

Interventions

DRUG

Minocycline, then Minocycline/Lovastatin

Participants of this group will take 1 tablet of minocycline 50mg daily for 4 weeks, minocycline 100mg for the following 4 weeks and finally a combined treatment of minocycline 100 mg and lovastatin 40mg for the following 12 weeks.

DRUG

Lovastatin, then Minocycline/Lovastatin

Participants of this group will take 1 tablet of lovastatin 20 mg daily for 4 weeks, lovastatin 40 mg for the following 4 weeks and finally a combined treatment of minocycline 100 mg and lovastatin 40 mg for the following 12 weeks.

Trial Locations (1)

J1H 5N4

Centre de Recherche du CHUS, Sherbrooke